ISDA

Deposition Date 2009-02-13

Release Date 2009-06-02

Last Version Date 2023-11-01

Entry Detail

PDB ID:

3G9E

Keywords:

TRANSCRIPTION/TRANSFERASE

Title:

Aleglitaar. a new. potent, and balanced dual ppara/g agonist for the treatment of type II diabetes

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)
(Taxon ID: )

Host Organism:

Escherichia coli

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.30 Å

R-Value Free:

0.26

R-Value Work:

0.20

Space Group:

P 21 21 21

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Peroxisome proliferator-activated receptor gamma
Gene (Uniprot):PPARG
Chain IDs:A
Chain Length:271
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:P37231 Pfam ID:PF00104

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Nuclear receptor coactivator 1
Gene (Uniprot):NCOA1
Chain IDs:B
Chain Length:13
Number of Molecules:1
Biological Source:

UniProt ID:Q15788 EC:2.3.1.48

Ligand Molecules

RO7

Primary Citation

Aleglitazar, a new, potent, and balanced dual PPARalpha/gamma agonist for the treatment of type II diabetes.

Benardeau, A, Benz, J, Binggeli, A, Blum, D, Boehringer, M, Grether, U, Hilpert, H, Kuhn, B, Marki, H.P, Meyer, M, Puntener, K, Raab, S, Ruf, A, Schlatter, D, Mohr, P.Show

Bioorg.Med.Chem.Lett. 19 2468 2473 (2009)

PMID: 19349176 DOI: 10.1016/j.bmcl.2009.03.036

Abstact

Design, synthesis, and SAR of novel alpha-alkoxy-beta-arylpropionic acids as potent and balanced PPARalphagamma coagonists are described. One representative thereof, Aleglitazar ((S)-2Aa), was chosen for clinical development. Its X-ray structure in complex with both receptors as well as its high efficacy in animal models of T2D and dyslipidemia are also presented.

Legend

Protein

Chemical

Disease

Primary Citation of related structures